Form 4 for TVTX Travere Therapeutics, Inc.
Accepted 2026-02-19 00:00:00 ET · period of report 2026-02-17 · accession 0001283303-26-000005 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-02-19 | 2026-02-17 | TVTX | REED ELIZABETH E | CLO, GC | S - Sale+OE | $27.83 | -10.0K | 109.5K | -8% | -$278.3K |
| D | 2026-02-19 | 2026-02-17 | TVTX | REED ELIZABETH E | CLO, GC | M - OptEx | $19.08 | +10.0K | 115.2K | +10% | +$190.8K |
| D | 2026-02-19 | 2026-02-17 | TVTX | REED ELIZABETH E | CLO, GC | M - OptEx | $0.00 | -10.0K | 20.0K | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-17 | S | D | 4,321 | $28.26 | 105,211 | D | — | — | (F3) The weighted average sale price for the transaction reported was $28.262, and the range of prices were between $28.09 and $28.50. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. |
| 2 | Common | Common Stock | 2026-02-17 | M | A | 10,000 | $19.08 | 115,211 | D | — | — | |
| 3 | Common | Common Stock | 2026-02-17 | S | D | 5,679 | $27.50 | 109,532 | D | — | — | (F2) The weighted average sale price for the transaction reported was $27.504, and the range of prices were between $27.01 and $27.83. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. |
| 4 | Derivative | Employee stock option (right to buy) | 2026-02-17 | M | D | 10,000 | $0.00 | 20,000 | D | $19.08 · — to 2027-01-04 | 10,000 Common Stock | (F4) The stock option is fully vested and exercisable. |